Key result
In a canine model of healing myocardial infarction, E4031 increased the effective refractory period to repolarization time (ERP/RT) ratio predominantly in the infarct zone.
Why the study?
Does E4031 alter the effective refractory period and repolarization time in the healing phase of myocardial infarction in a canine model?
Does E4031 alter the effective refractory period and repolarization time in the healing phase of myocardial infarction in a canine model?
In a canine model of healing myocardial infarction, E4031 discordantly prolonged the refractory period more than the repolarization time in the infarct zone, providing a potential mechanism for both its antiarrhythmic and proarrhythmic effects.
Answers are grounded in this paper and cite their sources.
May explain dual arrhythmic potential of E4031 in infarct zones; leaves open translation to human post-MI arrhythmia management.
Susceptibility to reentrant tachyarrhythmias and the antiarrhythmic efficacy of class III agents are related more to the duration of the refractory period (ERP) than to the repolarization time (RT). We measured both ERP and RT in a canine model of healing myocardial infarction, and evaluated the effect of a class III agent (E4031) on these parameters and on the inducibility of ventricular tachyarrhythmias. ERP and RT on the unipolar electrogram were measured at several cycle lengths in the normal (NZ) and infarct zones (IZ), respectively, in 10 canine myocardial infarction models and extrastimulation was used to induce ventricular arrhythmias. Measurements were repeated after E4031 administration. At baseline, both ERP and RT were significantly longer in IZ than in NZ with ERP/RT ratio also higher in IZ. This ratio tended to increase at longer cycle lengths. E4031 increased ERP and RT both in NZ and IZ at all cycle lengths, but increased the ERP/RT ratio predominantly in IZ. E4031 prevented induction of sustained VT or VF, which was inducible in 3 out of 10 dogs at baseline, although it facilitated induction of VF in 1 dog with no baseline arrhythmia. By increasing the ERP/RT ratio, class III drugs may shorten the relative refractory period in IZ at the expense of a greater ERP difference created between NZ and IZ.
No takes yet. Share an insight, caveat, or question.
Takatsuki et al. (1998) studied Healing phase of myocardial infarction (n=10). E4031 vs. Baseline (pre-administration) was evaluated on Effective refractory period to repolarization time (ERP/RT) ratio in the infarct zone (p=<0.05). In a canine model of healing myocardial infarction, E4031 increased the effective refractory period to repolarization time (ERP/RT) ratio predominantly in the infarct zone.
Synapse has enriched 10 related papers. Consider them for comparative context: